# NHS Framework Agreement for the supply of Direct Oral Anticoagulants \(DOACs\) for the NHS in England

> Contract award record from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Contract winner: Bristol Myers Squibb
- Award value: £3,185,000,000
- Tender value: £3,185,000,000
- Award date: 15 November 2021
- Published: 25 November 2021
- Contract start: 1 January 2022
- Contract end: 31 March 2024
- Stage: awarded
- Procurement category: goods
- Notice ID: 5725a1be-e7d8-4f2b-a152-221c6a2968d5-488946
- OCID: ocds-b5fd17-c60280d9-a835-4dff-877a-3046d1b66e39

## Description

NHS Framework Agreement for the supply of Direct Oral Anticoagulants \(DOACs\) for the NHS in England\. Also known as Novel Oral Anticoagulants \(NOACs\)\. Period of Framework: 01/01/2022 - 31/03/2024 with an option to extend \(at the Authority's discretion\) for a further period \(or periods\) up to a total of 12 months \(i\.e\. total possible framework duration of 39 months\)

## Related contract awards

- [Transformation Delivery Services - Establishing Operational Excellence \(EOE\)](/contracts/ocds-b5fd17-b08595d2-8961-409b-9b62-7b01d7a64541): NHS England
- [Identity Access Management - Service Adoption and Enablement](/contracts/ocds-b5fd17-08ebad6c-84fb-4e62-9afd-d06d220dd3a5): NHS England
- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/5725a1be-e7d8-4f2b-a152-221c6a2968d5-488946)